/ajprenal. 00423.2003.-We investigated the hypothesis that thromboxane A 2 (TxA2)-prostaglandin H2 receptors (TP-Rs) mediate the hemodynamic responses and increase in reactive oxygen species (ROS) to ANG II (400 ng ⅐ kg Ϫ1 ⅐ min Ϫ1 sc for 14 days) using TP-R knockout (TP Ϫ/Ϫ) and wild-type (ϩ/ϩ) mice. TP Ϫ/Ϫ had normal basal mean arterial blood pressure (MAP) and glomerular filtration rate but reduced renal blood flow and increased filtration fraction (FF) and renal vascular resistance (RVR) and markers of ROS (thiobarbituric acid-reactive substances and 8-isoprostane PGF 2␣) and nitric oxide (NOx). Infusion of ANG II into TP ϩ/ϩ increased ROS and thromboxane B 2 (TxB2) and increased RVR and FF. ANG II infusion into TP Ϫ/Ϫ mice reduced ANG I and increased aldosterone but caused a blunted increase in MAP (TP Ϫ/Ϫ: ϩ6 Ϯ 2 vs. TP ϩ/ϩ: ϩ15 Ϯ 3 mmHg) and failed to increase FF, ROS, or TxB 2 but increased NOx and paradoxically decreased RVR (Ϫ2.1 Ϯ 1.7 vs. ϩ2.6 Ϯ 0.8Blockade of AT1 receptor of TP Ϫ/Ϫ mice infused with ANG II reduced MAP (Ϫ8 mmHg) and aldosterone but did not change the RVR or ROS. In conclusion, during an ANG II slow pressor response, AT 1 receptors activate TP-Rs that generate ROS and prostaglandins but inhibit NO. TP-Rs mediate all of the increase in RVR and FF, part of the increase in MAP, but are not implicated in the suppression of ANG I or increase in aldosterone. TP Ϫ/Ϫ mice have a basal increase in RVR and FF associated with ROS. thromboxane A 2-prostaglandin H2 receptor; isoprostane; hypertension; renal vascular resistance SUBCUTANEOUS ANG II infusion at 400 ng⅐ kg Ϫ1 ⅐min Ϫ1 causes a slow pressor response accompanied by oxygen free radical (O 2 Ϫ ⅐) formation and increased filtration fraction (FF) and renal vascular resistance (RVR). The important role of increased O 2 Ϫ ⅐ formation from nicotinamide adenine dinucleotide phosphate (NADPH) oxidase in the vasoconstrictor response to ANG II was first showed by Harrison and colleagues (15). We showed later that ANG II increased NADPH oxidase activity in the kidney and the expression of the p22 phox component in the renal afferent arteriole (6, 35). We and others also proposed a significant role for thromboxane A 2 (TxA 2 ) and other ligands for the TxA 2 -PGH 2 receptor (TP-R) in the pressor and renal hemodynamic response to ANG II (17, 18, 20 -22, 40, 42, 43). Under normal conditions, blood pressure (BP) is unaffected by a TxA 2 synthase inhibitor, TP-R blocker, or by TP-R gene knockout (13,28,40). However, during ANG II infusion, there is increased prostaglandin (PG) and TxA 2 generation (19), and blockade of TP-Rs blunts or prevents the pressor response and the increase in RVR (20 -22, 40, 43). However, the conclusion that TP-Rs have a critical role in the response to ANG II depends on the specificity of the drugs used. Therefore, this study was conducted in mice lacking functional TP-Rs by gene deletion.TP-Rs are expressed on systemic blood vessels and renal microvessels, glomeruli, mesangial cells, thick ascending limbs (TALs) of the loops of...